February 6, 2022 Comments Off on Drug Patent Expirations for the Week of February 6, 2022 Posted in: Uncategorized
SYMBICORT (budesonide; formoterol fumarate dihydrate) Astrazeneca Patent: 7,967,011 Expiration: Feb 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Pa…
February 6, 2022 Comments Off on New patent expiration for Genzyme Corp drug CAPRELSA Posted in: Uncategorized
Annual Drug Patent Expirations for CAPRELSA Caprelsa is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Genzyme Corp drug CAPRELSA appeared first …
